AGP Picks
View all

Niue Health Report
Provided by AGP

Niue Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Niue Health Report.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on June 2, 2026

Physicians Subjected to Unreliable ‘Lie-Detector’ Tests, according to the Journal of American Physicians and Surgeons
Jun. 2, 2026

Physicians Subjected to Unreliable ‘Lie-Detector’ Tests, according to the Journal of American Physicians and Surgeons

Indeterminate GlobeNewswire
Allsup Employment Services Highlights Ticket To Work Protection As SSA Centralizes Medical Disability Reviews
Jun. 2, 2026

Allsup Employment Services Highlights Ticket To Work Protection As SSA Centralizes Medical Disability Reviews

Indeterminate GlobeNewswire
AB Science : Stonegate Capital Partners updates its coverage of AB Science’s stock with a target price of EUR 4.25 per share
Jun. 2, 2026

AB Science : Stonegate Capital Partners updates its coverage of AB Science’s stock with a target price of EUR 4.25 per share

Indeterminate GlobeNewswire
Update on the Carbios - Wankai project in China
Jun. 2, 2026

Update on the Carbios - Wankai project in China

Indeterminate GlobeNewswire
Point d’avancement sur le projet Carbios - Wankai en Chine
Jun. 2, 2026

Point d’avancement sur le projet Carbios - Wankai en Chine

Indeterminate GlobeNewswire
NexTel Medical Corp. Executes Definitive Purchase Agreements to Acquire JumpstartRx and NueVistraMed, Expanding Telehealth Footprint and Accelerating Maxasome™ Commercialization
Jun. 2, 2026

NexTel Medical Corp. Executes Definitive Purchase Agreements to Acquire JumpstartRx and NueVistraMed, Expanding Telehealth Footprint and Accelerating Maxasome™ Commercialization

Indeterminate GlobeNewswire
FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients
Jun. 2, 2026

FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients

Indeterminate GlobeNewswire
Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference
Jun. 2, 2026

Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference

Indeterminate GlobeNewswire
New Study: Baby Gut Microbiome Differences Linked to Eczema and Food Allergy Emerge by 6 Months
Jun. 2, 2026

New Study: Baby Gut Microbiome Differences Linked to Eczema and Food Allergy Emerge by 6 Months

Indeterminate GlobeNewswire
MAIA Biotechnology Announces Open Market Purchases by CEO and Director
Jun. 2, 2026

MAIA Biotechnology Announces Open Market Purchases by CEO and Director

Indeterminate GlobeNewswire
USOSM Supports OMS Foundation Through 2026 Matching-Gift Incentive
Jun. 2, 2026

USOSM Supports OMS Foundation Through 2026 Matching-Gift Incentive

Indeterminate GlobeNewswire
Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026 Showcasing Initial Phase 1 In Vivo CAR-T Data with LB2501 in Non-Hodgkin Lymphoma (NHL)
Jun. 2, 2026

Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026 Showcasing Initial Phase 1 In Vivo CAR-T Data with LB2501 in Non-Hodgkin Lymphoma (NHL)

Indeterminate GlobeNewswire
Premier Health of America Announces Anticipated Delay in Filing Interim Financial Statements and Application for Management Cease Trade Order
Jun. 2, 2026

Premier Health of America Announces Anticipated Delay in Filing Interim Financial Statements and Application for Management Cease Trade Order

Indeterminate GlobeNewswire
Evosep and Molecular You Announce Strategic Collaboration to Scale Standardized Multi-Omic Testing Globally
Jun. 2, 2026

Evosep and Molecular You Announce Strategic Collaboration to Scale Standardized Multi-Omic Testing Globally

Indeterminate GlobeNewswire
Oncolytics Biotech® Announces Appointment of Steve Glover to Board of Directors and Promotion of John McAdory to Chief Operating Officer
Jun. 2, 2026

Oncolytics Biotech® Announces Appointment of Steve Glover to Board of Directors and Promotion of John McAdory to Chief Operating Officer

Indeterminate GlobeNewswire
Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris  
Jun. 2, 2026

Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris  

Indeterminate GlobeNewswire
ASHA: This Summer, Protect Your Hearing Without Missing the Fun
Jun. 2, 2026

ASHA: This Summer, Protect Your Hearing Without Missing the Fun

Indeterminate GlobeNewswire
Bay Area Lyme Ventures Invests in Galaxy Diagnostics to Advance Tick-Borne Disease Testing
Jun. 2, 2026

Bay Area Lyme Ventures Invests in Galaxy Diagnostics to Advance Tick-Borne Disease Testing

Indeterminate GlobeNewswire
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Advancing Proprietary Solutions Focused on Nanotechnology-Enabled Drug Delivery, AI-Enhanced Biomedical Infrastructure
Jun. 2, 2026

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Advancing Proprietary Solutions Focused on Nanotechnology-Enabled Drug Delivery, AI-Enhanced Biomedical Infrastructure

Indeterminate GlobeNewswire
TOMI Environmental Eyes Massive Expansion Opportunity as Food Industry Seeks Advanced Protection Against Emerging Pathogens
Jun. 2, 2026

TOMI Environmental Eyes Massive Expansion Opportunity as Food Industry Seeks Advanced Protection Against Emerging Pathogens

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Niue Health Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.